Next, we determined whether CPA-7 inhibits STAT3 activity in the RM-9 tumor model, CPA-7 was injected in the tail vein at final concentrations of either 0.75 or 1.5 mg/kg. The gene discussed is STAT3; the disease is neoplasm.